Evidence map›Paper›PMID 31506480›Full record

ArticleScientific reports2019

Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing.

Vivian W Xue, Moon T Cheung, Pak T Chan, Lewis L Y Luk, Vivian H Lee, Thomas C Au, Allen C Yu, William C S Cho, Hin Fung Andy Tsang, Amanda K Chan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Vivian W XueDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Moon T CheungDepartment of Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Pak T ChanDepartment of Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Lewis L Y LukDepartment of Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Vivian H LeeDepartment of Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Thomas C AuState Key Laboratory in Oncology in South China, Sir YK Pao Centre for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Sha Tin, Hong Kong, China.
Allen C YuDepartment of Computer Science, University of Oxford, Oxford, United Kingdom.
William C S ChoDepartment of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
Hin Fung Andy TsangDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong, China.
Amanda K ChanDepartment of Pathology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.
S C Cesar WongDepartment of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Kowloon, Hong Kong, China. cesar.wong@polyu.edu.hk.
Queen Elizabeth Hospital · CNHong Kong Polytechnic University · HKChinese University of Hong Kong · CNUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have developed an optimized protocol for plasma targeted mRNA sequencing in our previous study. Here, we performed plasma targeted mRNA sequencing for 40 colorectal adenoma patients and 39 colonoscopy-proven normal controls in order to find potential circulating mRNA markers for colorectal adenoma. Results showed that GSK3A and RHOA were differential expressed genes identified by a cut-off of fold change >2 and adjusted P value < 0.05. More detailed analysis showed that the expression of both GSK3A (0.01-fold with adjusted P < 1 × 10

Indexed as

Gene Expression Regulation, NeoplasticAdenomaBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsGene Expression ProfilingHumansPrognosisRNA, MessengerBiomarkers, TumorRNA, Messenger

Identifiers

PMID31506480
PMCPMC6736954
OpenAlexW2972657524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.